These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22325946)

  • 1. 3,4-Diarylpiperidines as potent renin inhibitors.
    Lacombe P; Arbour M; Aspiotis R; Cauchon E; Chen A; Dubé D; Falgueyret JP; Fournier PA; Gallant M; Grimm E; Han Y; Juteau H; Liu S; Mellon C; Ramtohul Y; Simard D; St-Jacques R; Tsui GC
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1953-7. PubMed ID: 22325946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and optimization of a substituted amino propanamide series of renin inhibitors for the treatment of hypertension.
    Chen A; Bayly C; Bezençon O; Richard-Bildstein S; Dubé D; Dubé L; Gagné S; Gallant M; Gaudreault M; Grimm E; Houle R; Lacombe P; Laliberté S; Lévesque JF; Liu S; MacDonald D; Mackay B; Martin D; McKay D; Powell D; Remen L; Soisson S; Toulmond S
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2204-9. PubMed ID: 20206513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of spirocyclic piperidines.
    Chen A; Aspiotis R; Campeau LC; Cauchon E; Chefson A; Ducharme Y; Falgueyret JP; Gagné S; Han Y; Houle R; Laliberté S; Larouche G; Lévesque JF; McKay D; Percival D
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7399-404. PubMed ID: 22071301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of tertiary alcohol-bearing piperidines.
    Chen A; Cauchon E; Chefson A; Dolman S; Ducharme Y; Dubé D; Falgueyret JP; Fournier PA; Gagné S; Gallant M; Grimm E; Han Y; Houle R; Huang JQ; Hughes G; Jûteau H; Lacombe P; Lauzon S; Lévesque JF; Liu S; Macdonald D; Mackay B; McKay D; Percival MD; St-Jacques R; Toulmond S
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3976-81. PubMed ID: 21641209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and optimization of renin inhibitors: Orally bioavailable alkyl amines.
    Tice CM; Xu Z; Yuan J; Simpson RD; Cacatian ST; Flaherty PT; Zhao W; Guo J; Ishchenko A; Singh SB; Wu Z; Scott BB; Bukhtiyarov Y; Berbaum J; Mason J; Panemangalore R; Cappiello MG; Müller D; Harrison RK; McGeehan GM; Dillard LW; Baldwin JJ; Claremon DA
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3541-5. PubMed ID: 19457666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and optimization of new piperidines as renin inhibitors.
    Corminboeuf O; Bezençon O; Grisostomi C; Remeň L; Richard-Bildstein S; Bur D; Prade L; Hess P; Strickner P; Fischli W; Steiner B; Treiber A
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6286-90. PubMed ID: 20843686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The discovery and preparation of disubstituted novel amino-aryl-piperidine-based renin inhibitors.
    Cody WL; Holsworth DD; Powell NA; Jalaie M; Zhang E; Wang W; Samas B; Bryant J; Ostroski R; Ryan MJ; Edmunds JJ
    Bioorg Med Chem; 2005 Jan; 13(1):59-68. PubMed ID: 15582452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discovery and synthesis of potent zwitterionic inhibitors of renin.
    Aspiotis R; Chen A; Cauchon E; Dubé D; Falgueyret JP; Gagné S; Gallant M; Grimm EL; Houle R; Juteau H; Lacombe P; Laliberté S; Lévesque JF; MacDonald D; McKay D; Percival MD; Roy P; Soisson SM; Wu T
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2430-6. PubMed ID: 21429746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and optimization of novel (3S,5R)-5-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)piperidine-3-carboxamides as orally active renin inhibitors.
    Mori Y; Ogawa Y; Mochizuki A; Nakamura Y; Fujimoto T; Sugita C; Miyazaki S; Tamaki K; Nagayama T; Nagai Y; Inoue S; Chiba K; Nishi T
    Bioorg Med Chem; 2013 Sep; 21(18):5907-22. PubMed ID: 23886807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of pyridone-substituted piperidines.
    Chen A; Campeau LC; Cauchon E; Chefson A; Ducharme Y; Dubé D; Falgueyret JP; Fournier PA; Gagné S; Grimm E; Han Y; Houle R; Huang JQ; Lacombe P; Laliberté S; Lévesque JF; Liu S; MacDonald D; Mackay B; McKay D; Percival MD; Regan C; Regan H; St-Jacques R; Toulmond S
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3970-5. PubMed ID: 21621998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphenyl/diphenyl ether renin inhibitors: filling the S1 pocket of renin via the S3 pocket.
    Yuan J; Simpson RD; Zhao W; Tice CM; Xu Z; Cacatian S; Jia L; Flaherty PT; Guo J; Ishchenko A; Wu Z; McKeever BM; Scott BB; Bukhtiyarov Y; Berbaum J; Panemangalore R; Bentley R; Doe CP; Harrison RK; McGeehan GM; Singh SB; Dillard LW; Baldwin JJ; Claremon DA
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4836-43. PubMed ID: 21741239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a new biaryl scaffold generating potent renin inhibitors.
    Lacombe P; Aspiotis R; Bayly C; Chen A; Dubé D; Fortin R; Gallant M; Juteau H; Liu S; McKay D; Roy P; Wu T
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5822-6. PubMed ID: 20728350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of orally bioavailable alkyl amine renin inhibitors.
    Xu Z; Cacatian S; Yuan J; Simpson RD; Jia L; Zhao W; Tice CM; Flaherty PT; Guo J; Ishchenko A; Singh SB; Wu Z; McKeever BM; Scott BB; Bukhtiyarov Y; Berbaum J; Mason J; Panemangalore R; Cappiello MG; Bentley R; Doe CP; Harrison RK; McGeehan GM; Dillard LW; Baldwin JJ; Claremon DA
    Bioorg Med Chem Lett; 2010 Jan; 20(2):694-9. PubMed ID: 19959358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 4,4-disubstituted piperidine-based C-C chemokine receptor-5 inhibitors with high potency against human immunodeficiency virus-1 and an improved human ether-a-go-go related gene (hERG) profile.
    Kazmierski WM; Anderson DL; Aquino C; Chauder BA; Duan M; Ferris R; Kenakin T; Koble CS; Lang DG; McIntyre MS; Peckham J; Watson C; Wheelan P; Spaltenstein A; Wire MB; Svolto A; Youngman M
    J Med Chem; 2011 Jun; 54(11):3756-67. PubMed ID: 21539377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of passive permeability and gut efflux transport on the oral bioavailability of novel series of piperidine-based renin inhibitors in rodents.
    Lévesque JF; Bleasby K; Chefson A; Chen A; Dubé D; Ducharme Y; Fournier PA; Gagné S; Gallant M; Grimm E; Hafey M; Han Y; Houle R; Lacombe P; Laliberté S; MacDonald D; Mackay B; Papp R; Tschirret-Guth R
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5547-51. PubMed ID: 21784634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of potent, isoxazole-containing renin inhibitors.
    Fournier PA; Arbour M; Cauchon E; Chen A; Chefson A; Ducharme Y; Falgueyret JP; Gagné S; Grimm E; Han Y; Houle R; Lacombe P; Lévesque JF; MacDonald D; Mackay B; McKay D; Percival MD; Ramtohul Y; St-Jacques R; Toulmond S
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2670-4. PubMed ID: 22450130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel class of oral direct renin inhibitors: highly potent 3,5-disubstituted piperidines bearing a tricyclic p3-p1 pharmacophore.
    Ostermann N; Ruedisser S; Ehrhardt C; Breitenstein W; Marzinzik A; Jacoby E; Vangrevelinghe E; Ottl J; Klumpp M; Hartwieg JC; Cumin F; Hassiepen U; Trappe J; Sedrani R; Geisse S; Gerhartz B; Richert P; Francotte E; Wagner T; Krömer M; Kosaka T; Webb RL; Rigel DF; Maibaum J; Baeschlin DK
    J Med Chem; 2013 Mar; 56(6):2196-206. PubMed ID: 23360239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of hERG inhibitory activity in the 4-piperidinyl urea series of H3 antagonists.
    Berlin M; Lee YJ; Boyce CW; Wang Y; Aslanian R; McCormick KD; Sorota S; Williams SM; West RE; Korfmacher W
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2359-64. PubMed ID: 20188550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct renin inhibitors as a new therapy for hypertension.
    Webb RL; Schiering N; Sedrani R; Maibaum J
    J Med Chem; 2010 Nov; 53(21):7490-520. PubMed ID: 20731374
    [No Abstract]   [Full Text] [Related]  

  • 20. Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels.
    Yang ZQ; Barrow JC; Shipe WD; Schlegel KA; Shu Y; Yang FV; Lindsley CW; Rittle KE; Bock MG; Hartman GD; Uebele VN; Nuss CE; Fox SV; Kraus RL; Doran SM; Connolly TM; Tang C; Ballard JE; Kuo Y; Adarayan ED; Prueksaritanont T; Zrada MM; Marino MJ; Graufelds VK; DiLella AG; Reynolds IJ; Vargas HM; Bunting PB; Woltmann RF; Magee MM; Koblan KS; Renger JJ
    J Med Chem; 2008 Oct; 51(20):6471-7. PubMed ID: 18817368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.